Antidepressants Flashcards
NE and and Specific Serotoninergic Antidepressants (NaSSA)
Mirtazapine
Presynaptic α2-adrenoceptor antagonist, 5HT2, 5HT3 antagonist, H1 receptor antagonist
Antidepressant, sedative effect
Major Depression
SE: Weight gain, sedation
Anxiolytics BZD vs Barbiturates
BZD increases the ion channel opening frequencyBarbiturates, in turn, prolong the ion channel opening time
BZD
Positive Allosteric modulators of the GABA A receptor complex
Non-selective binding to alpha subunits α1-5 enhances receptor affinity
Low dose sedative effect, high dose hypnotic
Flumazenil
negative GABA modulator,which reduces GABA attachment
Short acting BZD
Midazolam
T1 / 2 ~ 1.5-2.5 h i / v
Introductory anesthesia
Premedication prior to diagnostic or therapeutic manipulation
Seizures
Alprazolam
Bromazepam
Anxiolytic, muscle relaxant, sedative, hypnotic action
NB! Unlike barbiturates, anxiolytic doses of BZD do not cause
very severe sedation, i.e. dose dependent effect(see proportional comparison of effects)
Panic attacks, anxiety
Stress symptomatic therapy
CI: Driving
Problems of BZD therapy
- Tolerance
- Addiction
- Rebound effect
Non BZD, 2nd gen anxiolytics
Buspirone Partial serotonin (5HT1A) receptor agonist Lack of sedative function, habituation and addiction.
Although no interaction with alcohol has been found, nor driving is affected, individual patient response should be monitored at least at the start of therapy
Unlike BZD, the effects of B. develop much more slowly, within ~ 2 weeks
Anxiolytic effects
Generalized anxiety disorder
Barbituric acid derivatives or barbiturates
Phenobarbital
1.Directly affects the chloride channel of the GABA A complex, acts as a GABA A receptor agonist
2. Acts as a GABA A positive allosteric modulator (binding site subunit)
Barbiturates prolong GABA action
Dependence,addiction problem - barbituromania!
Cardiac neurosis, vegetative agitation
Sleep disorders
Epilepsy
IA: Induction of cytochrome CYP enzymes!
BZD analog
Zolpidem
«Group Z»the chemical structure is different but the mechanism of action is similar to BZD
Selective association with the GABA A-α1 subunit
Importantly, not in all GABA -A complex-forming subunit variations
α1 subunits are involved
Unlike BZD - muscle relaxant and antiepileptic activity is minimal, risk of tolerance and addiction is minimal
Hypnotic effect (no anxiolytic effect)
For the short-term treatment of sleep disorders
SE: somnambulism, hallucinations
Flumazenil
can prevent sedation caused by BZD and BZD analogues.
There is no antagonist for barbiturate intoxication.Use of BZD alone can rarely cause fatalities, but they contribute to another
CNS depressants such as alcohol